Applied DNA Announces Third Quarter Fiscal 2021 Aug 12, 2021 04:05PM
Applied DNA Sciences (APDN) Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer Apr 26, 2021 08:33AM
Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer Apr 26, 2021 08:30AM
Applied DNA Sciences (APDN) Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication Feb 25, 2021 09:06AM
Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication Feb 25, 2021 09:00AM


Jan 15, 2021 07:02AM Applied DNA Sciences (APDN) Reports Business Update on COVID-19 Diagnostics and Testing
Jan 15, 2021 07:00AM Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing
Jan 8, 2021 01:45PM Applied DNA Sciences (APDN) Notes FDA Lists its COVID-19 Assay Kit as 1 of Only 2 Able to Detect U.K. Variant
Jan 8, 2021 01:43PM U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)
Jan 4, 2021 08:00AM Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
Dec 17, 2020 04:05PM Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results
Dec 17, 2020 01:10PM Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government
Dec 11, 2020 08:00AM Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
Nov 30, 2020 07:07AM Applied DNA Sciences (APDN) EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
Nov 30, 2020 07:00AM Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
Nov 27, 2020 10:39AM Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3
Nov 25, 2020 08:00AM Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA
Oct 8, 2020 09:00AM Applied DNA Announces Repayment of Secured Convertible Notes
Apr 14, 2020 08:30AM Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5